Posted by Michael Wonder on 11 May 2020
Lung cancer victims miss out in drug funding boost - advocates
11 May 2020 - Advocates for lung cancer sufferers say the extra funding for PHARMAC in this year's Budget won't help them.
PHARMAC is getting an extra $160 million over four years to secure approved medicines.
The Combined Pharmaceutical Budget is managed by PHARMAC and covers district health boards' purchasing of medicines, vaccines, medical devices and other treatments.
